The chairman of an outside committee of medical experts that advises the Food and Drug Administration on drug-safety issues said Friday the agency’s own drug-safety oversight board needed to be more open and transparent. The chairman of the committee recommended that the FDA add new members to its oversight board.
Admitted to practice law in all federal multidistrict litigation courts, the California State Bar and the Florida Bar. His philosophy is to provide aggressive, quality representations and seek fair compensation for individuals and their families who have suffered injury, death, or sexual abuse.
Comments for this article are closed.